康弘药业：依帕司他片取得药品注册证书

Core Viewpoint - Kanghong Pharmaceutical has received the drug registration certificate for Ipatasertib tablets from the National Medical Products Administration, indicating approval for the treatment of diabetic neuropathy [1] Company Summary - Kanghong Pharmaceutical (002773.SZ) has recently announced the approval of Ipatasertib tablets, which are specifically indicated for diabetic neuropathy [1]